FDA Approves IL-15 Receptor Agonist for BCG-Unresponsive NMIBC | GU Oncology Now
The FDA approved Anktiva for patients with BCG-unresponsive NMIBC with CIS with or without papillary tumors.
The FDA approved Anktiva for patients with BCG-unresponsive NMIBC with CIS with or without papillary tumors.
Amid damning COVID emails, Fauci advisor Morens apologizes but offers few answers in tense congressional hearing.
Mazyar Shadman, MD, MPH, joins the Oncology Brothers, Rohit Gosain, MD; and Rahul Gosain, MD, to discuss the FDA approval of zanubrutinib and where it…
Want to get involved in cancer prevention? It’s easier than you think! Here are 4 ways to get started.
In today’s health-conscious world, where natural remedies are increasingly sought after, one solution stands out for its scientifically backed effectiveness….
EuroPCR 24 – Dr Roxana Mehran (Mount Sinai Hospital, US) outlines the findings of the ABILITY Global Diabetes study onsite at EuroPCR 2024.The ABILITY study…
Families Forum publishes footage – taken from the terrorists’ boydcams – showing the abduction of five female IDF soldiers, who are still held hostage in…
In powerful Instagram post, Nasrin Kadri implores followers to recognize suffering of hostages and calls for immediate action to bring them home
Stroke risks, symptoms and outcomes are not always the same for women and men.
Amid damning COVID emails, Fauci advisor Morens apologizes but offers few answers in tense congressional hearing.